Advisory Research’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-20,439
Closed -$991K 303
2020
Q2
$991K Buy
20,439
+5
+0% +$242 0.09% 170
2020
Q1
$863K Buy
20,434
+486
+2% +$20.5K 0.06% 142
2019
Q4
$853K Buy
+19,948
New +$853K 0.04% 197
2017
Q2
Sell
-12,757
Closed -$439K 425
2017
Q1
$439K Buy
+12,757
New +$439K 0.01% 363